Anthracycline-associated cardiotoxicity in adults: systematic review on the cardioprotective role of beta-blockers
Update on pathophysiology and preventive strategies of anthracycline‐induced cardiotoxicity - Corremans - 2019 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
Molecular-Level Understanding of the Anticancer Action Mechanism of Anthracyclines | IntechOpen
Anthracyclines
Idamycin (Idarubicin): Uses, Dosage, Side Effects, Interactions, Warning
Idarubicin Fact Sheet - Everything You Should Know
Cardiotoxicity associated with cancer therapy: Pathophysiology and prevention | Revista Portuguesa de Cardiologia
New insights into the activities and toxicities of the old anticancer drug doxorubicin - van der Zanden - - The FEBS Journal - Wiley Online Library
CANCER CHEMOTHERAPY PHARMACOLOGY Leo Mascarenhas MD MS 1
IJMS | Free Full-Text | Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives | HTML
PDF) Anthracyclines and Anthracenediones
The mechanism of idarubicin-induced DNA damage in the presence of... | Download Scientific Diagram
Medicinal chemistry-Anticancer agents
Idarubicin, an Anthracycline, Induces Oxidative DNA Damage in the Presence of Copper (II) | Anticancer Research
Module 1: Introduction to Enediyne Class of Natural Products Lecture 1 : History of Discovery of Enediynes and History of Cancer 1 2 3 4 1.2.6. The Anticancer Antibiotics Analysis of the number and sources of anticancer and antiinfective agents, indicates ...
The influence of charge and lipophilicity of daunorubicin and idarubicin on their penetration of model biological membranes – Langmuir monolayer and electrochemical studies - ScienceDirect
The mechanism of idarubicin-induced DNA damage in the presence of... | Download Scientific Diagram
Idamycin - FDA prescribing information, side effects and uses
Anthracyclines - an overview | ScienceDirect Topics
Cancers | Free Full-Text | HDAC Inhibitors in Acute Myeloid Leukemia | HTML
Daunorubicin - Wikipedia
Chemical structure of idarubicin and daunorubicin. | Download Scientific Diagram
Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate | Bentham Science
Targeting acute myeloid leukemia with TP53-independent vosaroxin | Future Oncology
Anthracyclines – Callaix
